These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2760 related items for PubMed ID: 27154724

  • 21. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A, Gustafsson R, Kalamajski S, Krams R, Segers D, Rauch U, Roos G, Nilsson J, Oldberg Å, Hultgårdh-Nilsson A.
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [Abstract] [Full Text] [Related]

  • 22. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ, Krishack PA, Lukens JR, Bhanvadia CV, Getz GS, Reardon CA.
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [Abstract] [Full Text] [Related]

  • 23. Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe-deficient mice.
    Higashi Y, Sukhanov S, Shai SY, Danchuk S, Snarski P, Li Z, Hou X, Hamblin MH, Woods TC, Wang M, Wang D, Yu H, Korthuis RJ, Yoshida T, Delafontaine P.
    Am J Physiol Heart Circ Physiol; 2020 Oct 01; 319(4):H730-H743. PubMed ID: 32795184
    [Abstract] [Full Text] [Related]

  • 24. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H, Li X, Zhang X, Liu Y, Huang S, Wang X.
    Cardiovasc Pathol; 2014 Oct 01; 23(3):169-74. PubMed ID: 24561077
    [Abstract] [Full Text] [Related]

  • 25. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G, Tian H, Qin S, Sun X, Yao S, Zong C, Luo Y, Liu J, Yu Y, Sang H, Wang X.
    Atherosclerosis; 2012 Mar 01; 221(1):55-65. PubMed ID: 22209213
    [Abstract] [Full Text] [Related]

  • 26. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ, Waseem TC, Galkina EV.
    Arterioscler Thromb Vasc Biol; 2016 Aug 01; 36(8):1496-506. PubMed ID: 27365405
    [Abstract] [Full Text] [Related]

  • 27. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X, Andonova T, Walker ME, Dalli J, Arnardottir H, Gisterå A, Thul S, Wheelock CE, Paulsson-Berne G, Ketelhuth DFJ, Hansson GK, Bäck M.
    Circulation; 2018 Oct 16; 138(16):1693-1705. PubMed ID: 29739755
    [Abstract] [Full Text] [Related]

  • 28. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
    Zhou W, Lin J, Chen H, Wang J, Liu Y, Xia M.
    Br J Nutr; 2015 Aug 28; 114(4):509-18. PubMed ID: 26201974
    [Abstract] [Full Text] [Related]

  • 29. LongShengZhi Capsule Reduces Established Atherosclerotic Lesions in apoE-Deficient Mice by Ameliorating Hepatic Lipid Metabolism and Inhibiting Inflammation.
    Ma J, Zhao D, Wang X, Ma C, Feng K, Zhang S, Chen Y, Zhu Y, Gao X, Zhao B, Wang Y, Qian K, Li X, Duan Y, Han J, Yang X.
    J Cardiovasc Pharmacol; 2019 Feb 28; 73(2):105-117. PubMed ID: 30540683
    [Abstract] [Full Text] [Related]

  • 30. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.
    Shnerb Ganor R, Harats D, Schiby G, Gailani D, Levkovitz H, Avivi C, Tamarin I, Shaish A, Salomon O.
    Arterioscler Thromb Vasc Biol; 2016 Mar 28; 36(3):475-81. PubMed ID: 26800563
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha.
    Lu KY, Ching LC, Su KH, Yu YB, Kou YR, Hsiao SH, Huang YC, Chen CY, Cheng LC, Pan CC, Lee TS.
    Circulation; 2010 Apr 27; 121(16):1828-37. PubMed ID: 20385932
    [Abstract] [Full Text] [Related]

  • 32. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
    Yang G, Lei Y, Inoue A, Piao L, Hu L, Jiang H, Sasaki T, Wu H, Xu W, Yu C, Zhao G, Ogasawara S, Okumura K, Kuzuya M, Cheng XW.
    Atherosclerosis; 2017 Sep 27; 264():1-10. PubMed ID: 28734203
    [Abstract] [Full Text] [Related]

  • 33. Progranulin in the hematopoietic compartment protects mice from atherosclerosis.
    Nguyen AD, Nguyen TA, Singh RK, Eberlé D, Zhang J, Abate JP, Robles A, Koliwad S, Huang EJ, Maxfield FR, Walther TC, Farese RV.
    Atherosclerosis; 2018 Oct 27; 277():145-154. PubMed ID: 30212683
    [Abstract] [Full Text] [Related]

  • 34. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P, Gandhi C, Prakash P, Dhanesha N, Grumbach IM, Dailey ME, Lentz SR, Chauhan AK.
    Arterioscler Thromb Vasc Biol; 2015 Nov 27; 35(11):2391-400. PubMed ID: 26427793
    [Abstract] [Full Text] [Related]

  • 35. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T.
    Atherosclerosis; 2010 Sep 27; 212(1):70-7. PubMed ID: 20684826
    [Abstract] [Full Text] [Related]

  • 36. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
    Calpe-Berdiel L, Zhao Y, de Graauw M, Ye D, van Santbrink PJ, Mommaas AM, Foks A, Bot M, Meurs I, Kuiper J, Mack JT, Van Eck M, Tew KD, van Berkel TJ.
    Atherosclerosis; 2012 Aug 27; 223(2):332-41. PubMed ID: 22748276
    [Abstract] [Full Text] [Related]

  • 37. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
    Rinne P, Guillamat-Prats R, Rami M, Bindila L, Ring L, Lyytikäinen LP, Raitoharju E, Oksala N, Lehtimäki T, Weber C, van der Vorst EPC, Steffens S.
    Arterioscler Thromb Vasc Biol; 2018 Nov 27; 38(11):2562-2575. PubMed ID: 30354245
    [Abstract] [Full Text] [Related]

  • 38. Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis.
    Aarup A, Pedersen TX, Junker N, Christoffersen C, Bartels ED, Madsen M, Nielsen CH, Nielsen LB.
    Arterioscler Thromb Vasc Biol; 2016 Sep 27; 36(9):1782-90. PubMed ID: 27444197
    [Abstract] [Full Text] [Related]

  • 39. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE-/- mice.
    Qian L, Ma L, Wu G, Yu Q, Lin H, Ying Q, Wen D, Gao C.
    Vascul Pharmacol; 2017 Feb 27; 89():49-57. PubMed ID: 28069546
    [Abstract] [Full Text] [Related]

  • 40. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ, Nahon JE, Reuwer AQ, Van Eck M, Hoekstra M.
    Br J Pharmacol; 2015 May 27; 172(9):2397-405. PubMed ID: 25572138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 138.